Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
Xinxin Huang, Juncheng Hao, Yan Qin Tan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2642-2642
Open Access | Times Cited: 11

Showing 11 citing articles:

The role of CXCL family members in different diseases
Chenjia Zhou, Ying Gao, Peilun Ding, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 96
Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro
Yilin Dai, Jing Xu, Xiaofeng Gong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 886-886
Open Access | Times Cited: 9
Redefining learning: student-centered strategies for academic and personal growth
Vipul Bhardwaj, Shuwei Zhang, Yan Qin Tan, et al.
Frontiers in Education (2025) Vol. 10
Open Access | Times Cited: 1
From Defense to Disease: How the Immune System Fuels Epithelial–Mesenchymal Transition in Ovarian Cancer
Michał Kos, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4041-4041
Open Access
The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer
Tesfaye Wolde, Vipul Bhardwaj, Md. Reyad‐ul‐Ferdous, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7996-7996
Open Access | Times Cited: 3
Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment
Christine Pampeno, Silvana Opp, Alicia Hurtado, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2925-2925
Open Access | Times Cited: 2
Immune‐Hot tumor features associated with recurrence in early‐stage ovarian clear cell carcinoma
Ruby Yun‐Ju Huang, Kuan‐Ju Huang, Ko‐Chen Chen, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 10, pp. 2174-2185
Closed Access | Times Cited: 6
Identification of STEAP3-based molecular subtype and risk model in ovarian cancer
Zouyu Zhao, Chongfeng Sun, Jishuai Hou, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4
ANGPTL8 links inflammation and poor differentiation, which are characteristics of malignant renal cell carcinoma
Takuo Matsukawa, Tomomitsu Doi, Kunie Obayashi, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1410-1422
Open Access | Times Cited: 6
Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies
Qihui Wu, Ruotong Tian, Xiaoyun He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
A.V. Asaturova, Anna Tregubova, Alina Magnaeva
Interdisciplinary cancer research (2022)
Closed Access
Page 1

Scroll to top